AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27515885 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuan-Sin-Yin (KSY) herbal decoction, 100 mL daily for 6 weeks
Number of subjects: 70
Study 27515885 — intervention group
Group type: COMPARATOR
Intervention: Placebo herbal decoction, 100 mL daily for 6 weeks
Number of subjects: 70
Study 23489742 — intervention group
Group type: EXPERIMENTAL
Intervention: nTMS
Number of subjects: 18
Study 23489742 — intervention group
Group type: COMPARATOR
Intervention: cTMS
Number of subjects: 18
Study 23775525 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric-restricted diet
Number of subjects: 19
Study 21169172 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention without normative feedback
Number of subjects: 575
Study 21169172 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention with normative feedback
Number of subjects: 575
Study 21169172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 575
Study 19105251 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 45
Study 19105251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 17019893 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of nodes of placental surface arteries
Number of subjects: 26
Study 17019893 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental weights
Number of subjects: 26
Study 17019893 — intervention group
Group type: EXPERIMENTAL
Intervention: Topological factor (number of nodes)
Number of subjects: 26
Study 12911589 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 217
Study 12911589 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 217
Study 12911589 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 217
Study 11286466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg daily)
Number of subjects: 83
Study 11286466 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 83
Study 11286466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 83
Study 9296940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Augmentin 1.2 g
Number of subjects: 32
Study 9296940 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibiotic)
Number of subjects: 32
Study 9296940 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 8282140 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol (8 mg/day first week, 4 mg/day second and third week, 2 mg/day fourth week)
Number of subjects: 62
Study 8282140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 8282140 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol
Number of subjects: 62
Study 3735179 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (moderate intensity, nonsocial)
Number of subjects: 14
Study 3735179 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 14
Study 29653270 — intervention group
Group type: EXPERIMENTAL
Intervention: Early decompressive craniotomy (within 6 hours of presentation)
Number of subjects: 46
Study 29653270 — intervention group
Group type: COMPARATOR
Intervention: Delayed decompressive craniotomy (followed until deterioration of consciousness)
Number of subjects: 46
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners treating homeless people (HP)
Number of subjects: 150
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived difficulties in treating HP
Number of subjects: 150
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of medical information
Number of subjects: 150
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient's compliance
Number of subjects: 150
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: Loneliness in practice
Number of subjects: 150
Study 27903566 — intervention group
Group type: EXPERIMENTAL
Intervention: Time required for the doctor
Number of subjects: 150
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessment of spinal pain prevalence
Number of subjects: 1348
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessment of spinal pain prevalence
Number of subjects: 1348
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessment of frequent pain
Number of subjects: 1348
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessment of frequent pain
Number of subjects: 1348
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-year incidence of spinal pain
Number of subjects: 1348
Study 24885549 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression of pain over two years
Number of subjects: 1348
Study 22726470 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopist training (two 1-hour training sessions)
Number of subjects: 1231
Study 20406589 — intervention group
Group type: EXPERIMENTAL
Intervention: Coseasonal therapy with 5000 AU/week for 6 weeks
Number of subjects: 33
Study 20406589 — intervention group
Group type: EXPERIMENTAL
Intervention: Precoseasonal therapy with 3000 AU/week for 10 weeks
Number of subjects: 33
Study 20406589 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 33
Study 19731175 — intervention group
Group type: EXPERIMENTAL
Intervention: With hand grip (WG)
Number of subjects: 15
Study 19731175 — intervention group
Group type: COMPARATOR
Intervention: Without hand grip (WOHG)
Number of subjects: 15
Study 15708385 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg, two doses six months apart)
Number of subjects: 702
Study 15708385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 702
Study 15708385 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 702
Study 12592272 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg every 6 hours for two doses
Number of subjects: 111
Study 12592272 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone insert 10 mg for one dose intravaginally
Number of subjects: 111
Study 12592272 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone gel 0.5 mg every 6 hours for two doses
Number of subjects: 111
Study 12592272 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 111
Study 12592272 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone gel
Number of subjects: 111
Study 12592272 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone insert
Number of subjects: 111
Study 10495374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 10495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 0.01 mg
Number of subjects: 249
Study 10495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 0.05 mg
Number of subjects: 249
Study 10495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 0.2 mg
Number of subjects: 249
Study 10495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg
Number of subjects: 249
Study 10495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 249
Study 8792367 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic tourniquet use during arthroscopic meniscectomy
Number of subjects: 34
Study 8792367 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet use during arthroscopic meniscectomy
Number of subjects: 34
Study 1716916 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 percent carboxyhemoglobin
Number of subjects: 41
Study 1716916 — intervention group
Group type: COMPARATOR
Intervention: room air
Number of subjects: 41
Study 1716916 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 percent carboxyhemoglobin
Number of subjects: 41
Study 7062377 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine irrigation
Number of subjects: 80
Study 7062377 — intervention group
Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 80
Study 31065046 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentrations of valine, leucine, isoleucine, phenylalanine, tyrosine, alanine, glutamate, ornithine, and lysine
Number of subjects: 284
Study 31065046 — intervention group
Group type: EXPERIMENTAL
Intervention: High glutamine concentrations
Number of subjects: 284
Study 31065046 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for homeostasis model assessment of insulin resistance
Number of subjects: 284
Study 28811733 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement and planning (CEP)
Number of subjects: 423
Study 28811733 — intervention group
Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 423
Study 25582097 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application counseling
Number of subjects: 120
Study 25582097 — intervention group
Group type: COMPARATOR
Intervention: Health educator counseling
Number of subjects: 120
Study 23860105 — intervention group
Group type: EXPERIMENTAL
Intervention: Padma Digestin (2 × 3 capsules daily for 6 weeks)
Number of subjects: 37
Study 23860105 — intervention group
Group type: EXPERIMENTAL
Intervention: Padma Digestin
Number of subjects: 37
Study 21865569 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 servings of vegetables (130 g)
Number of subjects: 49
Study 21865569 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 servings of vegetables (287 g)
Number of subjects: 49
Study 21865569 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 servings of vegetables (614 g)
Number of subjects: 49
Study 21865569 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of vegetables
Number of subjects: 49
Study 21865569 — intervention group
Group type: COMPARATOR
Intervention: Control for oxidative stress and inflammation
Number of subjects: 49
Study 19967149 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day (n = 28)
Number of subjects: 56
Study 19967149 — intervention group
Group type: COMPARATOR
Intervention: Control group (no statins, n = 28)
Number of subjects: 56
Study 17720325 — intervention group
Group type: COMPARATOR
Intervention: BI (1 session)
Number of subjects: 249
Study 17720325 — intervention group
Group type: EXPERIMENTAL
Intervention: BIB (2 sessions)
Number of subjects: 249
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmented air cushion
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Contoured viscous fluid/foam cushion
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Air/foam cushion
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Backrest height referenced to T12
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Backrest height referenced to inferior scapular angle
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Backrest height referenced to scapular spine
Number of subjects: 22
Study 14997965 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased posterior pelvic tilt
Number of subjects: 22
Study 11113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg orally 3 times daily
Number of subjects: 101
Study 11113085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 11113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 101
Study 9194783 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic infiltration of the wound before incision
Number of subjects: 43
Study 9194783 — intervention group
Group type: COMPARATOR
Intervention: Saline infiltration
Number of subjects: 43
Study 1549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 90 mg
Number of subjects: 0
Study 1549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 180 mg
Number of subjects: 0
Study 1549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 360 mg
Number of subjects: 0
Study 1549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 540 mg
Number of subjects: 0
Study 1549966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2421976 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 31
Study 2421976 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 31
Study 2421976 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 70 (0.5 L)
Number of subjects: 31
Study 31603996 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg
Number of subjects: 2000
Study 31603996 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 2000
Study 28744931 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition workshop (50 minutes)
Number of subjects: 3291
Study 28744931 — intervention group
Group type: COMPARATOR
Intervention: Promotion of unhealthy beverages
Number of subjects: 3291
Study 24758073 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept plus Tripterygium wilfordii polyglycoside (TWP)
Number of subjects: 46
Study 24758073 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 46
Study 22659533 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on ezetimibe (10 mg/day)
Number of subjects: 100
Study 22659533 — intervention group
Group type: COMPARATOR
Intervention: Double-dose pravastatin
Number of subjects: 100
Study 20129634 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline-chloroquine
Number of subjects: 936
Study 20129634 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 936
Study 18589030 — intervention group
Group type: EXPERIMENTAL
Intervention: Algal-oil capsules (600 mg DHA/day)
Number of subjects: 32
Study 18589030 — intervention group
Group type: COMPARATOR
Intervention: Cooked salmon (assayed portions)
Number of subjects: 32
Study 15964928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydrobiopterin (BH(4), 500 microg/min)
Number of subjects: 8
Study 15964928 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (24 mg/min)
Number of subjects: 8
Study 15964928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 15964928 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 8
Study 15964928 — intervention group
Group type: COMPARATOR
Intervention: LPS
Number of subjects: 8
Study 11796586 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent meningococcal B OMV vaccine
Number of subjects: 134
Study 10320158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lactated Ringer's solution (LR)
Number of subjects: 18
Study 10320158 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (NS)
Number of subjects: 18
Study 8916607 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase fluid intake by 500 cc
Number of subjects: 32
Study 8916607 — intervention group
Group type: COMPARATOR
Intervention: Maintain fluid intake at baseline level
Number of subjects: 32
Study 8916607 — intervention group
Group type: COMPARATOR
Intervention: Decrease fluid intake by 300 cc
Number of subjects: 32
Study 1790544 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg daily for 60 days
Number of subjects: 20
Study 1790544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6125089 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.75 mg to 3 mg per day, average final dose: 1.59 mg)
Number of subjects: 74
Study 6125089 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (3 mg to 12 mg per day, average final dose: 5.97 mg)
Number of subjects: 74
Study 6125089 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 74
Study 6125089 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 74
Study 31665879 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi training plus routine exercise
Number of subjects: 41
Study 31665879 — intervention group
Group type: COMPARATOR
Intervention: Routine exercise
Number of subjects: 41
Study 31095627 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CAD/CAM generated intermediate wafer
Number of subjects: 20
Study 31095627 — intervention group
Group type: COMPARATOR
Intervention: Conventional CAD/CAM generated intermediate wafer
Number of subjects: 20
Study 28379800 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight variability (measured according to average successive variability)
Number of subjects: 9509
Study 28379800 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight variability (highest quintile)
Number of subjects: 9509
Study 26513005 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate Milk (CM)
Number of subjects: 12
Study 26513005 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 12
Study 24953582 — intervention group
Group type: EXPERIMENTAL
Intervention: Community and school-based events incorporating an animated film, skits, and public pledging ceremonies
Number of subjects: 14
Study 24953582 — intervention group
Group type: COMPARATOR
Intervention: Shortened intervention (after control villages received it)
Number of subjects: 14
Study 22237883 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid emulsion containing medium-chain triglycerides (MCTs), soybean, olive, and fish oils
Number of subjects: 53
Study 22237883 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil emulsion
Number of subjects: 53
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: FiberWire
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticron
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of both FDP and FDS tendons
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of FDP only
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of one slip of FDS and resection of the other
Number of subjects: 10
Study 19345873 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection of 1 slip of FDS tendon
Number of subjects: 10
Study 17727574 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin for PMNE associated with nocturnal polyuria
Number of subjects: 0
Study 17727574 — intervention group
Group type: EXPERIMENTAL
Intervention: Alarms for PMNE with reduced bladder capacity
Number of subjects: 0
Study 17727574 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies for refractory cases of NE
Number of subjects: 0
Study 17727574 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutinin for a small subgroup with overactive bladder during sleep
Number of subjects: 0
Study 15246890 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/day
Number of subjects: 46
Study 15246890 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study 11432111 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 91
Study 11432111 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 91
Study 9699022 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-enriched yeast supplementation (4.8 mg yeast containing 5 microgram selenium daily via naso-gastric drip for 14 days)
Number of subjects: 28
Study 9699022 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented (control) group
Number of subjects: 28
Study 7795013 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program developed by unit 304 of Louis H. Lafontaine Hospital
Number of subjects: 0
Study 7795013 — intervention group
Group type: COMPARATOR
Intervention: Control patients (paired by age, sex, and years of hospitalization)
Number of subjects: 0
Study 2506874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid 20% administered to ten infants
Number of subjects: 19
Study 2506874 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil rubbed six times daily on the skin of nine infants
Number of subjects: 19
Study 2506874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid administered to four patients who had previously received sunflower seed oil
Number of subjects: 19
Study 2506874 — intervention group
Group type: COMPARATOR
Intervention: Topical application of sunflower seed oil
Number of subjects: 19
Study 155294 — intervention group
Group type: EXPERIMENTAL
Intervention: ipratropin
Number of subjects: 24
Study 155294 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 24
Study 30094626 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly recommended dosing of omeprazole
Number of subjects: 64
Study 30094626 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal dosing of omeprazole
Number of subjects: 64
Study 27663604 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered TIPS (n = 29)
Number of subjects: 62
Study 27663604 — intervention group
Group type: COMPARATOR
Intervention: LVP+A (n = 33)
Number of subjects: 62
Study 27663604 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 25968578 — intervention group
Group type: EXPERIMENTAL
Intervention: Hindlimb unloading (HU) in wild-type (WT) mice for 14 days
Number of subjects: 0
Study 25968578 — intervention group
Group type: EXPERIMENTAL
Intervention: Hindlimb unloading (HU) in MyD88(‐/‐) mice for 14 days
Number of subjects: 0
Study 25968578 — intervention group
Group type: COMPARATOR
Intervention: 5 days of bed rest in older adults
Number of subjects: 0
Study 23987013 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous bone pate for atticus reconstitution and mastoid cavity obliteration in canal wall down mastoidectomy with tympanoplasty
Number of subjects: 60
Study 23987013 — intervention group
Group type: COMPARATOR
Intervention: Canal wall down mastoidectomy with tympanoplasty (control group)
Number of subjects: 60
Study 21300730 — intervention group
Group type: EXPERIMENTAL
Intervention: AAIR pacing
Number of subjects: 1415
Study 21300730 — intervention group
Group type: COMPARATOR
Intervention: DDDR pacing
Number of subjects: 1415
Study 18472409 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (n=233)
Number of subjects: 563